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Abstract
Background Arteriovenous malformations (AVMs) are com-
munications between an artery and a vein outside the capillary
level. This pathologic communication may be either a fistula,
a simple communication between a single artery and a dilated
vein, or a more complex communication, a nidus of tortuous
channels between one or more arteries/arterioles and one or
more draining veins. The latter type of lesion is most frequent-
ly seen in the extremities; in the kidney they tend to appear
more rarely. The most common clinical presentation of renal
arteriovenous malformations (RAVMs) is haematuria.
Percutaneous treatment with selective endovascular tech-
niques offers a minimally invasive, nephron-sparing option
in comparison to the more invasive surgical approaches. The
purpose of this pictorial review is to highlight the general lines
of management and to show the range of imaging findings of
the percutaneous treatment of RAVMs.
Methods The imaging characteristics of a selection of cases of
percutaneously managed congenital RAVMs are presented
and the most common lines of approach are discussed.
Conclusion The imaging spectrum of diagnosis and percuta-
neous treatment of RAVMs is presented in order to aid inter-
pretation and endovascular management.
Teaching points
• Renal arteriovenous malformations are very rare lesions.
•Clinical expression is usually haematuria.
• Diagnosis is made with CT or MRI but the gold standard is
digital subtraction angiography.
•Catheter-directed treatment with the use of coils or liquid
embolics is minimally invasive, safe and effective.
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Introduction
The abnormal communications between arteries and veins
outside the capillary level are called arteriovenous
malformations (AVMs) and result from a failed embryologic
vascular development process. The dysplastic connectionmay
be between a single arterial feeder and a draining vein that is
usually enlarged, and this is the case of the arteriovenous
fistulas or AVFs, or between a conglomerate of arterial
branches and tortuous channels forming a nidus and one or
more draining veins. Both types may be present in the renal
vasculature in the form of either congenital renal arteriove-
nous fistulas (CRAVFs) or renal arteriovenous malformations
(RAVMs).
Vascular and interventional radiologists should recog-
nise such complex lesions and offer a definitive treatment
under the elective or emergency setting whenever possi-
ble. The purpose of this pictorial review is to highlight the
general lines of approach and to show the range of imag-
ing findings of diagnosis and the percutaneous
endovascular treatment of RAVMs.
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Aetiology
The abnormal communications between arteries and veins
within the renal vasculature are acquired in approximately
75% of the cases and the result of an iatrogenic injury
(most commonly biopsies), trauma or tumour [1–11].
Congenital RAVMs are significantly more rare, with re-
ported incidence of 0.04% at autopsy. Approximately 200
cases have been reported to date [2, 11–15]. RAVMs and
CRAVMs used to be classified as variceal and as cavern-
ous malformations, respectively [4, 7, 9, 10]. However,
since the introduction of the Mulliken and Glowacki clas-
sification for vascular malformations and the criteria set
by the International Society for Study of Vascular
Anomalies, these terms have been abandoned [10, 16].
RAVMs appear more frequently in women (3:1), more
often involving the right kidney. They represent sponta-
neous failures of vascular development usually occurring
between the 4th–10th week of embryonic life leading to
dysplastic subepithelial vessel formation lacking elastic
lamina, located in the calyceal or pelvic submucosa [17].
Clinical presentation
The most common clinical presentation (75% of the
cases) is macro- or microhaematuria [11, 18, 19].
Haematuria occurs because of dysplastic vessel rupture
within the urinary collecting system and may become life
threatening in many cases of major blood loss. The sever-
ity of haematuria is irrelevant to the size of the lesion;
even small RAVMs may lead to severe blood loss if
located near the pelvicalyceal system. If the blood loss
is slow, clots may be formed that block the pelicalyceal
system leading to urinary obstruction and flank pain.
Hypertension may also be seen and may be related to
al tered f low dynamics within the renal ar tery.
Congestive heart failure is usually seen in cases with
relatively large congenital fistulas rather than RAVMs.
In such cases the patients usually present with atrial
fibrillation and symptoms of right heart failure such as
raised arterial and blood jugular venous pressure, palpable
liver edge, jaundice and lower limb oedema. However,
symptoms of heart failure are usually delayed, and no
clinical suspicion of the fistula is present. The incidence
of atrial fibrillation is not clear.
Imaging methods and findings
Assessment with ultrasound (US) using an abdominal 2–
4-MHz convex probe may be the initial approach in some
cases. RAVMs are hypoechoic lesions in the b-mode and
flow-filled lesions in colour-Doppler imaging with high
velocity (up to 60 cm/s) turbulent flow [20]. Turbulent
flow with an arterial spectrum may also be detected with-
in the inferior vena cava (IVC) in case a high-flow AVM
is located in the right kidney. If the AVM is located in the
left kidney, dilatation of the ipsilateral renal vein may be
noticed.
Computed tomography (CT) is a very useful tool for the
evaluation of RAVMs. A non-contrast-enhanced scan is usu-
ally performed to rule out the presence of urinary stones or
calcifications. A biphasic scan is carried out in arterial and
delayed venous phase (90–120 s) as per the haematuria pro-
tocol to investigate other potential causes of haematuria. The
arterial phase images are expected to reveal the presence of
tortuous small arteries with thin ramifications and in some
cases the early filling of the IVC too. Small RAVMs may not
be detectable with CT scans. Therefore, in case of persistent
unexplained microhaematuria digital subtraction angiography
(DSA; see below) is suggested to investigate the presence of a
small RAVM.
Magnetic resonance imaging (MRI) may also be used and
in this case the RAVM appears as a flow-void area on T2-
weighted (T2-w) images. Early filling of the IVC may be seen
after i.v. contrast medium administration (Fig. 1). MRI might
be indicated, instead of CT in young patients because of the
lack of ionising radiation.
The gold standard for the diagnosis/characterisation of
RAVMs is DSA, which offers the possibility to evaluate the
lesion dynamically, delineate the feeder branches anatomical-
ly and plan the treatment. Retrograde puncture of the right
common femoral artery is usually performed; a 4- or 5-F
sheath is inserted followed by selective catheterisation of the
renal artery. Automated pump injection (3–4 cc/s and 12 cc in
total) of contrast medium is usually done via a 4- or a 5-F
catheter located at the ostium of the renal artery and a 2-3
frames/s angiogram is performed. DSA will demonstrate the
feeding arteries and super-selective catheterisation with the
use of a microcatheter may follow, if necessary. Angiography
of both kidneys is advisable, since rarely bilateral RAVMs
may be present.
Management
When haematuria is clinically manifested and the diagnosis
of an RAVM has been established, urgent treatment plan-
ning is required. Especially if haematuria is life threaten-
ing, an emergency approach is necessary. Surgical options
include total or partial nephrectomy [21]. However, surgi-
cal options are invasive, require several days of
hospitalisation and are related to high morbidity because
of the risk of complete loss of renal function and the risk of
herniation of the lateral abdominal wall [22]. Therefore,
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percutaneous embolisation techniques have been devel-
oped for the management of such complex lesions
[23–25]. Such procedures are performed under local an-
aesthesia in the majority of the cases.
Embolisation techniques aim at permanent occlusion of the
multiple small channels between arteries and veins that form
the nidus of the AVM and all the arterial feeders. The outcome
of the procedure depends on the technique and the type of
embolic material used. Usually several feeding arteries are
involved at the segmental and interlobar level. Every feeding
artery needs to be examined angiographically.
The embolic material used for the treatment of RAVMs
may be Gelfoam, absolute alcohol, polyvinyl alcohol (PVA),
coils and liquid embolic materials such as n-butyl 2-
cyanoacrylate (NBCA) glue and ethylene vinyl alcohol co-
polymer (Onyx, Covidien, USA).
Embolisation with gelfoam
Gelfoam or absorbable gelatin sponge has been used as the
first choice in the past and has resulted in occlusion or
diminishing of the AVM [26]. However, this approach is not
permanent and haematuria may recur [10]. The Gelfoam
embolisation technique is only mentioned for historical pur-
poses and is not used in the current clinical practice of man-
agement of RAVMs.
Embolisation with alcohol
Embolisation with absolute alcohol aims to ablate the
lesion. The mechanism of alcohol ablation is not
completely clear. It seems to be based on a combination
of perivascular necrosis, endothelial damage, arterial
Fig. 1 A 38-year-old woman was admitted to the emergency department
because of acute right flank pain and severe macroscopic haematuria.
Medical history revealed right-sided nephrolithiasis for which she had
undergone three sessions of extracorporeal shock wave lithotripsy in the
past. Laboratory investigation revealed moderate anaemia and normal
renal function. Renal US ruled out hydronephrosis and neoplasia (not
shown). A small (10-mm) residual stone fragment detected in a single
calyx was not considered responsible for the haematuria. No ureteral
stones were detected with a non-contrast CT scan. Diagnostic cystoscopy
was within normal limits except for bleeding from the right ureteric
orifice. Diagnostic right-sided semi-rigid ureteroscopy excluded any
gross ureteral pathology.a-dMR imaging of the abdomen showed a small
low-signal-intensity lesion in the upper lobe of the right kidney on T2-w
TSE images (a). The lesion was not obvious on plain T1-w images. The
3D T1 gradient echo MR angiography showed early filling of a 1.5-cm
lesion (b, arrow) located in the subcortical parenchyma (c) with early
venous drainage directly to the inferior vena cava (d, arrow). Findings
were more conspicuous on the original thin-slice-thickness images rather
than theMIP reconstructions. These findings were consistent with RAVM
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spasm and sludging of erythrocytes leading to vessel
occlusion [27]. The use of absolute alcohol was very
popular in the past as it is very effective in occluding
the nidus and acts against renin-dependent hypertension
[28]. Migration to the pulmonary circulation did not raise
concern, since the alcohol solution is usually very diluted.
In a publication of Mitchel et al. in 2006 [29], the role
of alcohol was questioned in terms of complications con-
sidering that a case of cardiovascular collapse occurred.
The pathophysiology of the collapse was not clear; how-
ever it was attributed mainly to direct toxicity of alcohol
to the cardiac conduction system or to pulmonary artery
spasm. After this case the authors monitored the pulmo-
nary artery pressures during embolisaton with alcohol as a
standard practice to determine whether alcohol induces
pulmonary artery spasm and results in elevation of the
pulmonary artery systolic pressure. After 92 procedures
the authors reported a minor increase of the systolic blood
pressure (2.3 mmHg) and of the systolic pulmonary artery
pressure (1.0 mmHg), which was attributed to pain during
the procedure. Therefore the cause of the severe but
thankfully rare complications of alcohol was not clarified.
In order to be effective, alcohol must stagnate in con-
tact with the endothelium at least for several seconds.
Therefore, its use in high-flow malformations is not indi-
cated, unless the in- and outflow is mechanically almost
completely blocked. Reflux of alcohol in the arterial sys-
tem can be prevented with the use of a balloon catheter
(Berenstein Occlusion Balloon Catheter; Boston
Scientific) that can be wedged into the arterial branch
and inflated. Absolute alcohol needs to be slowly injected
by hand at a rate of approximately 0.1–0.2 ml/s after a test
injection at the same rate with the use of contrast material
to confirm the absence of reflux. Each injection needs to
be followed by the infusion of 1 ml of saline at the same
rate. At the end of the injection the catheter needs to be
slowly withdrawn and possible residual alcohol and debris
need to be aspirated. Otherwise two long sheaths may be
inserted from both the arterial and venous access and a
balloon may be inflated from the venous end to avoid
migration of alcohol in the venous system. More severe
complications have been noticed when PVA particles are
used. Nevertheless, embolisation with absolute alcohol is
not easily controllable, not tolerated by all patients and
may lead to complications. The main complications relat-
ed to alcohol infusion are dyspnoea and headache.
Symptoms are usually severe but last only for a couple
of minutes.
Takebayashi et al. [10] reported their experience in 30
patients submitted to 34 embolisation procedures for con-
trolling haematuria secondary to RAVMs over a 10-year
period. Combinations of gelatin sponge, PVA particles
and absolute alcohol were used. In 22 cases total and in
8 partial occlusion was achieved. After a mean follow-up
of 6.2 years massive haematuria recurred in four patients;
two were initially treated with gelatin sponges, one with
the combination of alcohol and gelatin sponges and one
with PVA. A significant percentage of renal parenchyma
infarction (mean 15.7 %) occurred in nearly all patients.
Non-target embolisation due to reflux of the embolic
agents occurred in three patients. Alcohol injection caused
transient dyspnoea and immediate headache in one pa-
tient. Infusion of alcohol or PVA into an RAVM with
marked arteriovenous shunting may cause dyspnoea and
Fig. 2 Same patient as in Fig. 1. a Emergency angiography with selec-
tive catheterisation of the right renal artery confirmed the presence of an
upper renal pole AVM. b Two major feeding arterial branches supplied
the AVM. Rapid venous filling through enlarged pool-like vascular
structures was demonstrated. Both sites were successfully embolised with
metallic coils of 3×2.6 (n=3), 4×4.0 (n=3) and 6×2.6 (n=1) mm
diameter (2DHelical-35, Boston Scientific, Cork, Ireland). The procedure
was uneventful, haematuria subsided immediately and the patient recov-
ered fully within the next few days
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headache, because less-diluted embolic material reaches
the lungs and the brain. However, the small dose of
alcohol that we use for ablation causes little tissue damage
because dilution of alcohol below 50% eliminates its
toxicity. In order to avoid this reaction, the alcohol should
be injected slowly, at a rate of less than 0.2 ml/s, while the
catheter is being placed selectively in the feeding vessel.
Multiple small perfusion defects were detected with scin-
tigraphy in the lung parenchyma in patients treated with
PVA. Renin-dependent hypertension occurred in the same
group of patients 6 months after embolisation. There was
a slight increase of serum creatinine levels in 14 patients,
but renal function remained within normal limits.
Embolisation with coils
The most commonly adopted embolic material for the treat-
ment of RAVMs is metallic coils (or microcoils), which are
mainly made from stainless steel or platinum [30–36] (Figs. 2
and 3). Coils, sized appropriately, offer a more controlled
embolisation. The coils are deployed in the feeding branches
of the lesion aiming to occlude the inflow. However, coils do
Fig. 3 A 33-year-old man was
admitted to the emergency
department because of acute right
flank pain and severe
macroscopic haematuria and
laboratory findings like the case
described in Figs. 1 and 2.
Contrast CTscan revealed a “bag-
of-worms”-like mass in the
middle portion of the right kidney
(not shown). a Emergency
angiography with selective
catheterisation of the right renal
artery confirmed an area of
tortuous, coiled vascular channels
with early filling of the renal vein
within a few seconds after
contrast injection in the centre of
the kidney (arrow). These
findings confirmed the RAVM
diagnosis, which appeared to
receive blood supply from three
small arterial branches. b Two of
the feeding branches were
successfully embolised with
metallic coils of 3×2.6 (n=4) mm
diameter (2D Helical-35, Boston
Scientific, Cork, Ireland). c The
middle feeding branch was closer
to the nidus (arrow), and
embolisation by injection of
tissue NBCA glue (GlueBran2,
GEM S.r.l., Viareggio, Italy) was
chosen. The final angiogram
showed a good post-embolisation
result. The haematuria stopped
and the patient recovered within
the next days
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not treat the nidus directly and success is not always guaran-
teed. Coils may alsomigrate and lead to pulmonary embolism,
but this is very unusual in the treatment of RAVMs where the
nidal vessels are small and most likely occurs in CRAVFs
where aneurysmal dilatation of the veins is present. Protection
balloons may be used in the arterial and venous system also in
the case of coil embolisation as described for alcohol.
Migration may be prevented with “caging” techniques as
described by Durack et al. [37], where an OptEase IVC filter
was used as a “cage” for coils. Yoon et al. [38] described a
migration of coils in the colon post embolisation of a renal
lesion due to erosion of the bowel wall from a local inflam-
matory reaction. However, judging from the number of coils
(no angiographic picture is provided) the treated lesion was
most likely a renal aneurysm rather than an RAVM.
Embolisation with liquid embolics
The use of liquid embolics offers the possibility to penetrate
deeper in the lesion and reach the nidus [23, 24, 39]. This is a
tool that needs to be used in experienced hands because
complications may occur in case of migration of the embolic
material into the venous circulation.
Liquid embolic material may be either n-butyl 2-
cyanoacrylate (NBCA) glue or ethylene vinyl alcohol copol-
ymer (Onyx, Covidien Europe). NBCA glue can be mixed
with lipiodol (usually 1:2) and after super selective nidus
catheterisation slow injection follows. Once the nidus has
been completely filled and the glue reaches the draining vein,
injection needs to be stopped and the microcatheter is usually
withdrawn within the carrying catheter (Fig. 3c). Before glue
injection, catheter filling with 5% glucose is mandatory. The
same fluid is used to clean the catheter after glue injection and
during catheter retrieval in order to prevent adhesion of the
catheter tip in the arterial vessel.
Onyx is a copolymer of ethylene vinyl alcohol dissolved in
dimethyl sulphoxide (DMSO). The composite is mixed with
tantalum powder to allow visualisation under fluoroscopy.
Embolisation procedures with the use of Onyx require cathe-
ters specifically designed for this liquid embolic material;
otherwise there is a risk of damage of the inner layer of the
catheter. In order to avoid premature precipitation of Onyx
within the catheter, the dead space of the catheter is filled with
DMSO.When the liquid embolic comes in contact with blood
or interstitial fluids a cast is formed that hardens in a centrip-
etal way. This offers the possibility of continues injection and
remodelling, considering that the inner layer is still flexible.
Fig. 4 A 72-year-old womanwas
admitted to the emergency
department because of right flank
pain and macroscopic haematuria.
Laboratory investigation revealed
haemoglobin of 9.3 mg/dl.
Abdominal US showed only
multiple clots within the urinary
bladder. a-b Contrast-enhanced
CT scan revealed a conglomerate
of vessels in the upper pole of the
right kidney, visible in arterial
phase with early filling of the IVC
(arrow). The diagnosis of RAVM
was made and the patient was
submitted to a selective right renal
angiogram using a hydrophilic 4-
F Simmons 1 catheter. c
Angiogram showed a tortuous
nidus in the RAVM at the level of
the upper renal pole with supply
from two different superior
branches without contrast blush,
which would have suggested
active bleeding. d Subsequent
embolisation with injection of
liquid embolic material (Onyx,
eV3 Europe SAS, Paris, France);
interval angiogram shows
exclusion of the upper lesion.
Angiogram of the lower lesion
followed
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There is one case in the literature of Onyx use to treat RAVM
[39]. The patient complained for persistent macroscopic
haematuria and a small RAVM was revealed with DSA fol-
lowing a negative CT scan. A small amount (0.4 ml) of liquid
embolic was used with a satisfactory result. A case of Onyx
treatment is shown in Fig. 4.
Finally, the combination of metallic coil placement and
glue injection is possible (Fig. 3). This approach can be used
in cases where coil treatment seems insufficient, and thus
additional glue injection can be performed. In case the appro-
priate coil size is not available or if the length of the feeding
branch is quite short and there is a possibility of coil migra-
tion, then glue is a better option.
Conclusion
RAVMs are rare lesions that may lead to severe haematuria.
Diagnosis is based on the presence of tortuous vessels within
the renal parenchyma in cross-sectional imaging, with early
venous filling in the contrast-enhanced pictures. Treatment
with transcatheter embolisation is based on the use of coils
or liquid embolic agents as well as the combination of both.
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